DDC

a nucleoside analog drug that inhibits HIV replication by interfering with the reverse transcriptase enzyme. The drug is FDA-approved for the treatment of HIV disease; current practice favors use in combinations. Adverse side effects may include nausea, peripheral neuropathy, oral ulcers and pancreatitis.